GLAND PHARMA
|
GLAND PHARMA Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹5,617 Cr | ₹5,665 Cr | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr |
| Sales | ₹4,178 Cr | ₹4,078 Cr | ₹3,272 Cr | ₹3,970 Cr | ₹3,131 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹1,406 Cr | ₹1,564 Cr | ₹319 Cr | ₹414 Cr | ₹292 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹33 Cr | ₹23 Cr | ₹33 Cr | ₹17 Cr | ₹39 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹5,617 Cr | ₹5,665 Cr | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹103 Cr | ₹128 Cr | ₹-47 Cr | ₹37 Cr | ₹-273 Cr |
| Raw Material Consumed | ₹1,987 Cr | ₹2,045 Cr | ₹1,732 Cr | ₹2,073 Cr | ₹1,492 Cr |
| Opening Raw Materials | ₹459 Cr | ₹979 Cr | ₹466 Cr | ₹530 Cr | ₹302 Cr |
| Purchases Raw Materials | ₹2,039 Cr | ₹1,502 Cr | ₹2,230 Cr | ₹1,983 Cr | ₹1,704 Cr |
| Closing Raw Materials | ₹526 Cr | ₹459 Cr | ₹979 Cr | ₹466 Cr | ₹530 Cr |
| Other Direct Purchases / Brought in cost | ₹14 Cr | ₹23 Cr | ₹16 Cr | ₹26 Cr | ₹16 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹199 Cr | ₹230 Cr | ₹125 Cr | ₹95 Cr | ₹75 Cr |
| Electricity & Power | ₹199 Cr | ₹230 Cr | ₹125 Cr | ₹95 Cr | ₹75 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹1,402 Cr | ₹1,257 Cr | ₹403 Cr | ₹339 Cr | ₹311 Cr |
| Salaries, Wages & Bonus | ₹1,063 Cr | ₹955 Cr | ₹363 Cr | ₹300 Cr | ₹260 Cr |
| Contributions to EPF & Pension Funds | ₹287 Cr | ₹252 Cr | ₹16 Cr | ₹13 Cr | ₹11 Cr |
| Workmen and Staff Welfare Expenses | ₹43 Cr | ₹40 Cr | ₹18 Cr | ₹15 Cr | ₹20 Cr |
| Other Employees Cost | ₹8.11 Cr | ₹10 Cr | ₹6.70 Cr | ₹11 Cr | ₹21 Cr |
| Other Manufacturing Expenses | ₹347 Cr | ₹327 Cr | ₹194 Cr | ₹180 Cr | ₹437 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹173 Cr | ₹151 Cr | ₹49 Cr | ₹45 Cr | ₹42 Cr |
| Packing Material Consumed | - | - | - | - | ₹273 Cr |
| Other Mfg Exp | ₹175 Cr | ₹176 Cr | ₹145 Cr | ₹135 Cr | ₹122 Cr |
| General and Administration Expenses | ₹207 Cr | ₹217 Cr | ₹121 Cr | ₹94 Cr | ₹59 Cr |
| Rent , Rates & Taxes | ₹82 Cr | ₹71 Cr | ₹65 Cr | ₹59 Cr | ₹38 Cr |
| Insurance | ₹31 Cr | ₹29 Cr | ₹11 Cr | ₹9.88 Cr | ₹6.37 Cr |
| Printing and stationery | ₹4.00 Cr | ₹4.09 Cr | ₹3.15 Cr | ₹3.29 Cr | ₹2.90 Cr |
| Professional and legal fees | ₹72 Cr | ₹94 Cr | ₹36 Cr | ₹19 Cr | ₹7.87 Cr |
| Traveling and conveyance | ₹7.39 Cr | ₹9.57 Cr | ₹3.85 Cr | ₹1.84 Cr | ₹1.39 Cr |
| Other Administration | ₹11 Cr | ₹9.10 Cr | ₹1.32 Cr | ₹1.28 Cr | ₹2.23 Cr |
| Selling and Distribution Expenses | ₹27 Cr | ₹37 Cr | ₹27 Cr | ₹41 Cr | ₹37 Cr |
| Advertisement & Sales Promotion | ₹3.31 Cr | ₹4.61 Cr | ₹4.56 Cr | ₹2.02 Cr | ₹1.95 Cr |
| Sales Commissions & Incentives | ₹0.93 Cr | ₹14 Cr | ₹2.76 Cr | ₹3.88 Cr | ₹1.77 Cr |
| Freight and Forwarding | ₹23 Cr | ₹19 Cr | ₹20 Cr | ₹35 Cr | ₹33 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹75 Cr | ₹90 Cr | ₹45 Cr | ₹33 Cr | ₹24 Cr |
| Bad debts /advances written off | ₹3.85 Cr | ₹7.59 Cr | ₹2.20 Cr | ₹0.34 Cr | ₹0.28 Cr |
| Provision for doubtful debts | ₹0.77 Cr | ₹14 Cr | - | ₹3.79 Cr | ₹0.12 Cr |
| Losson disposal of fixed assets(net) | ₹0.03 Cr | - | ₹0.08 Cr | ₹0.18 Cr | - |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹71 Cr | ₹68 Cr | ₹42 Cr | ₹28 Cr | ₹23 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹4,348 Cr | ₹4,332 Cr | ₹2,600 Cr | ₹2,891 Cr | ₹2,161 Cr |
| Operating Profit (Excl OI) | ₹1,269 Cr | ₹1,333 Cr | ₹1,025 Cr | ₹1,510 Cr | ₹1,302 Cr |
| Other Income | ₹214 Cr | ₹170 Cr | ₹240 Cr | ₹224 Cr | ₹135 Cr |
| Interest Received | ₹204 Cr | ₹151 Cr | ₹179 Cr | ₹139 Cr | ₹86 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | ₹0.25 Cr | - | - | ₹0.02 Cr |
| Profits on sale of Investments | - | ₹0.35 Cr | ₹2.85 Cr | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹0.26 Cr | ₹11 Cr | ₹57 Cr | ₹79 Cr | ₹41 Cr |
| Others | ₹9.07 Cr | ₹8.43 Cr | ₹1.05 Cr | ₹6.09 Cr | ₹8.28 Cr |
| Operating Profit | ₹1,483 Cr | ₹1,503 Cr | ₹1,265 Cr | ₹1,734 Cr | ₹1,437 Cr |
| Interest | ₹42 Cr | ₹26 Cr | ₹7.45 Cr | ₹5.24 Cr | ₹3.41 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹4.60 Cr | ₹4.41 Cr | ₹1.16 Cr | ₹1.84 Cr | ₹0.50 Cr |
| Other Interest | ₹37 Cr | ₹22 Cr | ₹6.29 Cr | ₹3.40 Cr | ₹2.91 Cr |
| PBDT | ₹1,441 Cr | ₹1,477 Cr | ₹1,258 Cr | ₹1,729 Cr | ₹1,434 Cr |
| Depreciation | ₹378 Cr | ₹345 Cr | ₹147 Cr | ₹110 Cr | ₹99 Cr |
| Profit Before Taxation & Exceptional Items | ₹1,063 Cr | ₹1,133 Cr | ₹1,111 Cr | ₹1,619 Cr | ₹1,335 Cr |
| Exceptional Income / Expenses | - | - | ₹-56 Cr | - | - |
| Profit Before Tax | ₹1,063 Cr | ₹1,133 Cr | ₹1,055 Cr | ₹1,619 Cr | ₹1,335 Cr |
| Provision for Tax | ₹364 Cr | ₹360 Cr | ₹274 Cr | ₹407 Cr | ₹338 Cr |
| Current Income Tax | ₹371 Cr | ₹349 Cr | ₹277 Cr | ₹396 Cr | ₹339 Cr |
| Deferred Tax | ₹-7.84 Cr | ₹14 Cr | ₹-2.80 Cr | ₹14 Cr | ₹0.12 Cr |
| Other taxes | ₹0.99 Cr | ₹-3.55 Cr | ₹-0.82 Cr | ₹-3.00 Cr | ₹-1.72 Cr |
| Profit After Tax | ₹699 Cr | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹699 Cr | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr | ₹3,026 Cr |
| Appropriations | ₹7,486 Cr | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹330 Cr | - | - | - | - |
| Equity Dividend % | ₹1,800.00 | ₹2,000.00 | - | - | - |
| Earnings Per Share | ₹42.40 | ₹46.90 | ₹47.42 | ₹73.75 | ₹60.94 |
| Adjusted EPS | ₹42.40 | ₹46.90 | ₹47.42 | ₹73.75 | ₹60.94 |
Compare Income Statement of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹43,188.8 Cr | 4.5% | 5% | 23.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 4.5% |
5% |
23.8% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses